Previous Close | 2.2500 |
Open | 2.2500 |
Bid | 6.4000 |
Ask | 10.6000 |
Strike | 320.00 |
Expire Date | 2024-11-15 |
Day's Range | 2.2500 - 2.2500 |
Contract Range | N/A |
Volume | |
Open Interest | 1 |
On May 15, 2024, James Edgemond, the Chief Financial Officer and Treasurer of United Therapeutics Corp (NASDAQ:UTHR), sold 40,160 shares of the company.
On May 15, 2024, Director Christopher Causey sold 2,000 shares of United Therapeutics Corp (NASDAQ:UTHR) as reported in a recent SEC Filing.